GlassScriptPhysician profile
Caleb Thomas Senn
NPI 1083241772
$3,725.12
in general payments reported to CMS, 2019-2025
12 companies · $630 in 2025
The $630 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $539 · 2023: $826 · 2024: $1,731 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452 · Travel and Lodging: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,451.61 |
| Travel and Lodging | $734.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,475.73 | 2022-2025 | Clareon, Lensx, Centurion |
| Sight Sciences, INC. | $263.12 | 2022-2024 | Omni Surgical System |
| Allergan, INC. | $197.06 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $152.61 | 2023 | Quatera 700, Rescan 700, Artevo 800 |
| Astellas Pharma US INC | $143.74 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $139.19 | 2025 | Veritas Vision System |
| Abbvie INC. | $128.39 | 2022-2025 | |
| Harrow Eye, LLC | $121.47 | 2024 | Verkazia, Iheezo, Flarex |
| Mallinckrodt Hospital Products INC. | $45.33 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $23.58 | 2024 | Scoutpro Osmolarity System |
| Ocular Therapeutix, INC. | $18.22 | 2025 | Dextenza |
| Glaukos Corporation | $16.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Senn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.